The MMACHC gene helps your body process vitamin B12 into forms your cells can use. If this gene does not work properly, certain substances can build up and may lead to feeding problems, poor growth, low energy, vision changes, and effects on the brain, blood, or kidneys. Many variants are harmless, while a few may cause cblC disease, an inherited condition that affects vitamin B12 processing. Early diagnosis and treatment can improve outcomes.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate activities in the body. Some genes provide the code for proteins, the parts of cells that do much of the work. Others mainly direct when certain processes happen, where they take place, and how active they are. As a group, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. For a more detailed look at this topic, you can learn more in the LearnHub.
Overview
MMACHCGene function
What if the gene works
The MMACHC gene helps cells process vitamin B12 into forms the body can use. This supports energy production and helps break down certain proteins and fats. It also helps keep the nervous system and blood cells healthy.
Risk
What if the gene does not work
Variants in the MMACHC gene cause cblC, affecting how the body uses vitamin B12. This can lead to developmental problems, eye disease, and nerve symptoms. Milder or more severe variants can change when signs begin and how severe they are.
Treatment
What does that mean for your treatment
Pathogenic variants in the MMACHC gene usually make hydroxocobalamin the main treatment, given by injection, often alongside betaine. Cyanocobalamin is generally not preferred because it is less effective in this setting. Treatment is often continued long term and adjusted to symptoms and lab results.
Conditions associated with MMACHC
Gene function
What if the gene works
Inside your cells, the MMACHC gene helps your body use vitamin B12 in a practical, everyday way. It prepares this vitamin so cells can turn it into the forms needed for normal chemical reactions. This supports how the body handles certain fats, proteins, and amino acids.
The MMACHC gene helps cells unpack vitamin B12 after it enters the cell. It removes attached chemical groups so the vitamin can move into the next steps of vitamin B12 processing.
This gene helps convert vitamin B12 into two active forms that cells can actually use. These forms are needed in different parts of the cell for routine metabolism.
One active B12 form supports reactions that help break down certain fats and proteins for energy. This is especially important in the cell area that acts like an energy center.
The other active B12 form helps cells recycle homocysteine into methionine, an amino acid used to build proteins and support many cell reactions. This helps the body use nutrients in a balanced way.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and are part of normal human variation, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic diversity. Sometimes, though, a variant changes how a gene works more significantly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the MMACHC gene can change the shape, stability, or amount of the MMACHC protein, so cells handle vitamin B12 less effectively. Some are milder and leave partial activity. More severe variants may shorten the protein or stop it from being made, causing a larger loss of function. This helps explain how variants in the MMACHC gene affect protein function and why the cblC condition can vary in age at onset and severity.
How variants are linked to conditions
Pathogenic variants in the MMACHC gene cause methylmalonic acidemia with homocystinuria, cblC type, often called cblC disease. In information about the MMACHC gene and methylmalonic acidemia with homocystinuria, this is the main well-established condition doctors mean. Symptoms can begin in infancy or later and may include feeding and growth problems, developmental delay, vision changes, blood abnormalities, or neurologic and psychiatric symptoms.
A variant is not necessarily a diagnosis
DNA variants are a normal feature of human biology and are common throughout the general population. Most have no direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some situations, though, a single variant in a specific gene that has been well characterized can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For MMACHC, risk is mainly set by inheritance: a child is affected when they inherit a harmful variant from both parents. Having a family history or a partner who carries an MMACHC variant raises the chance of having an affected child. Once someone has an MMACHC-related condition, lifestyle is not known to prevent it.
Inheritance of MMACHC variants
Variants in the MMACHC gene are inherited in an autosomal recessive pattern. This means a child needs to inherit two disease-causing variants, one from each parent, to have MMACHC-related cblC disease. Parents who each carry one variant are usually unaffected carriers, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a carrier child, and a 25% chance of having a child with neither variant. In families asking how MMACHC variants are inherited, this pattern means boys and girls are affected equally.
What does my MMACHC result mean for my family?
For families with an MMACHC-related condition, parents are usually healthy carriers, and brothers and sisters may also be affected or be carriers. Close relatives may want to learn whether the variant runs in the family, especially if there is a history of early feeding problems, low energy, vision problems, or developmental concerns in a child. Future children in the family may also be affected if both parents carry an MMACHC variant.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant, MMACHC genetic testing reads the MMACHC gene from a blood or saliva sample. Labs usually use sequencing to look for spelling changes and may also check for missing or extra pieces. Results can show whether a variant is present and whether it helps explain symptoms or carrier status.
When should I consider getting a genetic test?
Consider MMACHC testing if you or your child has signs of an inherited problem with using vitamin B12, such as developmental delay, eye problems, or certain unusual blood or urine test results. It can also help when there is a known family history or an affected relative.
A genetic result is only one part of your health story
A genetic finding can be informative, but how much it reveals depends on the condition and on the type of variant involved. Over time, many factors affect how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best considered together with other parts of care. In other situations, a genetic result may give a clear answer. In areas such as response to medication, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, seems weaker for another, or causes more side effects in someone else. Differences in how the body breaks down, moves, or responds to a drug are common and can shape both benefit and sensitivity. Medication response is also influenced by age, kidney and liver function, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics looks at how differences in genes can shape a person’s response to medication. It examines links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes affect either how strongly a drug works or how the body processes it. This understanding can support treatment decisions that are both better informed and more individualized. To explore this subject further, more information is available in the LearnHub.
Drugs influenced by the MMACHC gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how people respond to medicines, so questions about side effects, new symptoms, or changes to treatment are best discussed with your doctor or pharmacist.
History
Doctors first recognized the condition now linked to the MMACHC gene through children who had a mix of developmental, eye, and blood findings that did not fit better-known vitamin B12 problems. In the 1960s and 1970s, researchers grouped these cases under cblC disease, long before the gene itself was identified. Initially understood only through visible traits, later recognized as tied to a specific gene, this condition became a key part of research on inherited vitamin B12 processing. In 2006, scientists identified the MMACHC gene as the cause of cblC disease. That discovery helped explain why affected families could share a clear inherited pattern. From these first observations, research expanded steadily, improving diagnosis and newborn testing in some settings.